Zeev's Turnips Patch-No Politics (ZEEV)

[madrose1]

CMED China Medical Tech reports earnings of $0.26 on revs of $13.7 mln (33.49 )

Reports Q4 (Jun) earnings of $0.26 per share; revenues rose 61.5% year/year to $13.7 mln. CEO comments, "The strong year/year growth in our Q3 was primarily attributable to an increase in sales of both our HIFU therapy system and our ECLIA system, and is largely a reflection of continued acceptance by the medical community of these products. Sales of our reagent kits comprise a significant portion of our ECLIA revenues. We launched 11 new reagent kits during the quarter and now offer a total of 38 types of reagent kits. We intend to continue to allocate resources to support the growth of our ECLIA operations, including the development of reagents for other applications. We also intend to continue our efforts to increase awareness and acceptance in the Chinese medical community of our core product, the HIFU therapy system, to support the growth of our HIFU operations."